Follow us on twitter

FAQs

Expand All
How do I subscribe to Diabetologia?

Membership of the EASD includes online access to Diabetologia. Membership is available to students, individuals holding a medical degree or scientific workers with an academic degree. To join the EASD, please visit their membership page.

Alternatively, you can subscribe to Diabetologia via our publisher, Springer:

By email: subscriptions@springer.com
Online: Springer website
By telephone: +49(6221)3454242

How do I sign up for the Table of Content alert?

You will first be required to create a Springer account and will then be able to sign up to receive monthly table of contents alerts here

Does posting in a non-commercial pre-print server (such as arXiv, bioRxiv) preclude submission to Diabetologia?

No, posting on non-commercial pre-print servers does not constitute prior publication and hence this would not preclude submission to Diabetologia. If accepted, authors may update the version of the paper on the pre-print server with the version of the paper accepted by Diabetologia (see http://www.springer.com/gb/open-access/authors-rights/self-archiving-policy/2124).

Does posting an electronic copy of a PhD thesis in an open access repository violate Diabetologia's exclusivity policy and preclude publication in Diabetologia?

No.

My study was funded in whole or in part by one of the UK's Research Councils (RCUK). Is Diabetologia compliant with the Research Councils' Open Access policy?

Yes. Authors must select Springer’s Open Choice program. If the corresponding author on the paper is based at an institution with a Springer Compact agreement and the article type is covered by this agreement according to the ‘Current agreement partners’ information, your paper will qualify for free open choice. Otherwise, you will be charged an ‘Article Processing Charge’ of $3,000 USD. In both cases, The cost of having your article published with open access is covered by RCUK. Springer will immediately deposit the final published article in PubMed Central where it will be available at once. In line with RCUK policy, the paper will be published under the Creative Commons Attribution (CC BY) license which lets others modify, build upon and/or distribute the licensed work (including for commercial purposes) as long as the original author and source are credited, a link to the Creative Commons license is provided and any changes are indicated. For further information see Funder compliance.

Top of section

My study was funded by Wellcome Trust. The Trust requires papers to be made available on PubMed Central as soon as possible after publication, and certainly within six months of the publication date. How do I do this?

Please select Springer’s Open Choice program. If the corresponding author on the paper is based at an institution with a Springer Compact agreement and your article type is covered by this agreement according to the ‘Current agreement partners’ information, your paper will qualify for free open choice. Otherwise, you will be charged an ‘Article Processing Charge’ of $3,000 USD. In both cases, Springer will immediately deposit the final published article in PubMed Central where it will be available at once. For further information see Springer’s Wellcome Trust Compliance Policy. The cost of having your article published with open access is covered by the Wellcome Trust. Please see the Wellcome Trust’s Authors’ Guide for details. In line with the Wellcome Trust policy articles will be published under the Creative Commons Attribution (CC BY) license which lets others modify, build upon and/or distribute the licensed work (including for commercial purposes) as long as the original author and source are credited, a link to the Creative Commons license is provided and any changes are indicated (see the CC-BY page for more information).

Top of section

My study was funded by NIH and I have to submit my accepted article to PubMed Central. How do I do this?

Research funded by NIH must be made freely available in PubMed Central within 12 months of publication. This can be done via two routes:

  1. If you opt for Springer’s Open Choice program ($3,000 USD) then Springer will immediately deposit the final published article in PubMed Central where it will be available at once. For further information see Springer’s NIH Compliance Policy
  2. If you do not wish to pay for Open Choice then you may:

(a) submit your article to PubMed Central yourself – see http://publicaccess.nih.gov/submit_process.htm for instructions. You can submit your final author’s version to PubMed Central immediately upon publication, but it will only be made publicly available 12 months after publication. Please note that the publisher’s pdf version cannot be deposited on PubMed Central

or

(b) notify Springer within the ‘MyPublication process’ to deposit the author’s accepted version of your article into the NIH Manuscript Submission System (NIHMS), from where it will be sent to PubMed Central and made publicly available 12 months after publication. Springer will upload the accepted manuscript version of your article to NIHMS. Note that the uploaded article version corresponds to the final manuscript after peer-review and thus does not include any corrections you will carry out at a later stage (e.g. during proofing). Once your article is uploaded, you will receive email notification from NIHMS, asking you for approval of the upload to PubMed Central. When you have approved the upload, a web version of the article will be created by PubMed Central. Upon your approval of the web version, the PMCID will be created and can be found in the NIHMS. As soon as the article is displayed at PubMed Central, you will be able to find the PMCID by searching for your article.

For further information see Springer’s NIH Compliance Policy

Top of section

My research was funded by Telethon. Is Diabetologia compliant with their Open Access policy?

Yes. Authors must select Springer’s Open Choice program. If the corresponding author on the paper is based at an institution with a Springer Compact agreement and the article type is covered by this agreement according to the ‘Current agreement partners’ information, your paper will qualify for free open choice. Otherwise, you will be charged an ‘Article Processing Charge’ of $3,000 USD. In both cases, The cost of having your article published with open access is covered by Telethon. Springer will immediately deposit the final published article in PubMed Central where it will be available at once. In line with Telethon’s policy, the paper will be published under the Creative Commons Attribution (CC BY) license which lets others modify, build upon and/or distribute the licensed work (including for commercial purposes) as long as the original author and source are credited, a link to the Creative Commons license is provided and any changes are indicated. For further information see Funder compliance.

Top of section

How do I request permission to reproduce material published in Diabetologia?

All permission requests are handled via RightsLink. Please locate the article you are interested in on SpringerLink. Click on the ‘Reprints & Permissions’ button within ‘About this article’. Simply answer the on-screen questions to request the permission you require. For further information please see http://www.springer.com/rights?SGWID=0-122-12-372399-0.

If you have problems completing the permission online, please email Journalpermissions@springernature.com.

How do I order reprints of an article published in Diabetologia?

All reprint orders are handled by Springer Healthcare reprint representatives. To receive a quote or order reprints of Diabetologia content please contact Springer Healthcare by email: reprintswarehouse@springernature.com

Does Diabetologia publish supplements?

The only supplement published is the Abstract volume of the annual EASD meeting.

How do I advertise in Diabetologia?

Please contact Springer’s advertising department: tel: +49 (0)30 82 787 5731; e-mail raina.chandler@springer.com.

Does Diabetologia endorse conferences?

Please forward requests for endorsement of conferences directly to the EASD: e-mail secretariat@easd.org.

How do I become a referee for Diabetologia?

As a first step please ensure that we have an accurate record of your areas of interest on our database. Please go to http://mc.manuscriptcentral.com/diabetologia and update your account, or create a new account if necessary. Select only the keywords that best describe your main research interests.

Please be aware that even after you have created an account you may not be asked to serve as a referee as we have a very large pool of expert reviewers and our Associate Editors strive to find a good match between the referees’ expertise and the paper under review.

We are often contacted by scientists keen to review for us and are sorry not to be able to make any guarantees.

Top of section

Top